• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的多种表现

The Many Faces of Heart Failure.

作者信息

Snipelisky David, Chaudhry Sunit-Preet, Stewart Garrick C

机构信息

Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Advanced Heart Failure and Transplant, St. Vincent Heart Center, 8333 Naab Road, Indianapolis, IN 46260, USA.

出版信息

Card Electrophysiol Clin. 2019 Mar;11(1):11-20. doi: 10.1016/j.ccep.2018.11.001. Epub 2018 Dec 24.

DOI:10.1016/j.ccep.2018.11.001
PMID:30717842
Abstract

Heart failure is a heterogeneous clinical syndrome stemming from cardiac overload and injury that leads to considerable morbidity and mortality. This review highlights the many faces of heart failure, a major and growing public health problem, including its causes, classification, underlying pathophysiology, and variable progression. An individualized, patient-centered treatment approach that focuses on guideline-directed pharmacologic and device therapies is required for optimal management of this complex syndrome.

摘要

心力衰竭是一种异质性临床综合征,源于心脏负荷过重和损伤,可导致相当高的发病率和死亡率。本综述重点介绍了心力衰竭这一重大且日益严重的公共卫生问题的诸多方面,包括其病因、分类、潜在病理生理学以及不同的进展情况。对于这一复杂综合征的最佳管理,需要一种以患者为中心的个体化治疗方法,该方法侧重于遵循指南的药物和器械治疗。

相似文献

1
The Many Faces of Heart Failure.心力衰竭的多种表现
Card Electrophysiol Clin. 2019 Mar;11(1):11-20. doi: 10.1016/j.ccep.2018.11.001. Epub 2018 Dec 24.
2
Guideline for the management of heart failure caused by systolic dysfunction: Part I. Guideline development, etiology and diagnosis.收缩功能障碍所致心力衰竭管理指南:第一部分。指南制定、病因及诊断
Am Fam Physician. 2001 Sep 1;64(5):769-74.
3
Cardiac resynchronization therapy in cardiomyopathies.心肌病的心脏再同步治疗
J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):92-9. doi: 10.2459/JCM.0b013e3283637ff2.
4
Systolic heart failure: chronic and acute syndromes.收缩性心力衰竭:慢性和急性综合征。
Crit Care Med. 2008 Jan;36(1 Suppl):S44-51. doi: 10.1097/01.CCM.0000296267.84202.B0.
5
Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.与左心室收缩功能障碍相关的慢性心力衰竭的临床和药物治疗
Lippincotts Prim Care Pract. 1999 May-Jun;3(3):316-32.
6
Prognosis in heart failure: is systolic or diastolic dysfunction more important?心力衰竭的预后:收缩功能障碍还是舒张功能障碍更重要?
Herz. 1991 Sep;16 Spec No 1:324-9.
7
Advanced systolic heart failure: emerging pathophysiology and current management.晚期收缩性心力衰竭:新出现的病理生理学及当前治疗方法
Prog Cardiovasc Nurs. 1998 Summer;13(3):14-30.
8
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed.心力衰竭中的液体容量超负荷与充血:是时候重新审视病理生理学及容量评估方式了。
Circ Heart Fail. 2016 Aug;9(8):e002922. doi: 10.1161/CIRCHEARTFAILURE.115.002922.
9
Heart failure in elderly patients.老年患者的心力衰竭
Exp Gerontol. 2006 May;41(5):549-51. doi: 10.1016/j.exger.2006.03.002. Epub 2006 Apr 18.
10
Heart failure clinical guideline. South African Medical Association Heart Failure Working Group.心力衰竭临床指南。南非医学协会心力衰竭工作组。
S Afr Med J. 1998 Sep;88(9 Pt 2):1133-55.

引用本文的文献

1
Optimal Timing of Vericiguat Therapy in Patients with Heart Failure with Reduced/Mildly Reduced Ejection Fraction for Improving Mortality and Heart Failure Re-Hospitalization Rate.在射血分数降低/轻度降低的心力衰竭患者中,维立西呱治疗改善死亡率和心力衰竭再住院率的最佳时机
J Clin Med. 2025 Aug 19;14(16):5856. doi: 10.3390/jcm14165856.
2
Simultaneous Symptom Network Analysis of Heart Failure Patients: A Cross-Sectional Study.心力衰竭患者症状网络同步分析:一项横断面研究。
Risk Manag Healthc Policy. 2025 Jul 26;18:2493-2503. doi: 10.2147/RMHP.S520974. eCollection 2025.
3
Loganin ameliorates left ventricular fibrosis and dysfunction induced by pressure overload via the Sirt1/AKT/TGF-β1 signaling pathway.
马钱子苷通过Sirt1/AKT/TGF-β1信号通路改善压力超负荷诱导的左心室纤维化和功能障碍。
J Nat Med. 2025 May 10. doi: 10.1007/s11418-025-01911-9.
4
Targeting miR-144-5p/ACSM1 Axis Alleviates Doxorubicin-Induced Heart Failure by Inhibiting Lipid Peroxidation.靶向miR-144-5p/ACSM1轴通过抑制脂质过氧化减轻阿霉素诱导的心力衰竭
Curr Med Sci. 2025 May 5. doi: 10.1007/s11596-025-00053-z.
5
Lipid metabolism-associated metabolites on cardiovascular diseases: a two-sample Mendelian randomized study.脂质代谢相关代谢物与心血管疾病的关系:一项两样本孟德尔随机化研究
Front Cardiovasc Med. 2025 Mar 28;12:1445732. doi: 10.3389/fcvm.2025.1445732. eCollection 2025.
6
The Effect of Recombinant Human Brain Natriuretic Peptide Combined with Xinmailong on Heart Failure and Its Impact on Cardiac Function and Inflammatory Response.重组人脑利钠肽联合心脉隆对心力衰竭的影响及其对心功能和炎症反应的作用
Int J Gen Med. 2025 Apr 7;18:1999-2008. doi: 10.2147/IJGM.S509162. eCollection 2025.
7
Mendelian Randomization Study on the Associations Between Genetically Predicted Cardiovascular Disease Subtypes and the Risk of Developing Cardiomyopathies.关于基因预测的心血管疾病亚型与心肌病发生风险之间关联的孟德尔随机化研究。
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251328011. doi: 10.1177/10760296251328011. Epub 2025 Mar 28.
8
National shortage of home intravenous inotrope agents: The "inotrope pandemic" continues.国内家庭用静脉注射强心剂短缺:“强心剂大流行”仍在继续。
JHLT Open. 2023 Nov 19;3:100023. doi: 10.1016/j.jhlto.2023.100023. eCollection 2024 Feb.
9
Co-administration of isoprenaline and phenylephrine induced a new HFrEF mouse model through activation of both SNS and RAAS.异丙肾上腺素和去氧肾上腺素联合给药通过激活交感神经系统(SNS)和肾素-血管紧张素-醛固酮系统(RAAS)诱导了一种新的射血分数降低的心力衰竭(HFrEF)小鼠模型。
Front Cardiovasc Med. 2025 Mar 10;12:1531509. doi: 10.3389/fcvm.2025.1531509. eCollection 2025.
10
Effect of proton pump inhibitor (lansoprazole) on adverse drug reactions and rational drug use in elderly patients with chronic heart failure.质子泵抑制剂(兰索拉唑)对老年慢性心力衰竭患者药物不良反应及合理用药的影响
Am J Transl Res. 2025 Feb 15;17(2):1290-1301. doi: 10.62347/BZED8420. eCollection 2025.